TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • November 7th, 2017 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) by and between Paul Korner, M.D. (“Executive”) and Ardelyx, Inc. (the “Company”), is made effective as of the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
